WaferGen Bio-systems (WGBS) Misses Q1 EPS by 32c, Names New CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts quarterly revenue above estimates, fails to ignite shares
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
WaferGen Bio-systems Appoints Life Sciences Industry Veteran, Rolland D. Carlson, Ph.D., President & CEO
May 11, 2015 4:35 PM EDTFREMONT, Calif., May 11, 2015 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS) announced today that the Company has appointed Rolland D. Carlson, Ph.D., President & CEO, effective immediately. Dr. Carlson assumes this role from Ivan Trifunovich, Ph.D., who has served as President & CEO of WaferGen since March 2012. Dr. Trifunovich has been appointed Executive Chairman of WaferGen.
"With the significant progress we have achieved with single cell analysis, and a commercial launch on the near-term horizon, now is the right time for this transition to occur," said Dr. Trifunovich. ... More
WaferGen Bio-systems Reports Results for First Quarter 2015
May 11, 2015 4:30 PM EDTFREMONT, Calif., May 11, 2015 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NasdaqCM: WGBS) announced today its financial results for the first quarter ended March 31, 2015, and provided a corporate update.
Key Recent Highlights
Early Access Program for WaferGen's single cell analysis technology initiated; National Jewish Hospital and Karolinska Institutet join Genentech as WaferGen collaborators Entered into an industrial partnership with Procter & Gamble whereby Procter & Gamble will utilize WaferGen's SmartChip MyDesign quantitative PCR System to... More